...
首页> 外文期刊>Journal of Clinical Microbiology >Molecular Detection of Mycobacterium tuberculosis from Stools in Young Children by Use of a Novel Centrifugation-Free Processing Method
【24h】

Molecular Detection of Mycobacterium tuberculosis from Stools in Young Children by Use of a Novel Centrifugation-Free Processing Method

机译:利用新型无离心处理方法从幼儿凳子中分子检测结核分枝杆菌

获取原文
           

摘要

The microbiological diagnosis of tuberculosis (TB) in children is challenging, as it relies on the collection of relatively invasive specimens by trained health care workers, which is not feasible in many settings. Mycobacterium tuberculosis is detectable from the stools of children using molecular methods, but processing stool specimens is resource intensive. ABSTRACT The microbiological diagnosis of tuberculosis (TB) in children is challenging, as it relies on the collection of relatively invasive specimens by trained health care workers, which is not feasible in many settings. Mycobacterium tuberculosis is detectable from the stools of children using molecular methods, but processing stool specimens is resource intensive. We evaluated a novel, simple, centrifugation-free processing method for stool specimens for use on the Xpert MTB/RIF assay (Xpert), using two different stool masses: 0.6 g and a swab sample. Two hundred eighty children (median age, 15.5 months; 35 [12.5%] HIV infected) with suspected intrathoracic TB were enrolled from two sites in South Africa. Compared to a single Xpert test on respiratory specimens, the sensitivity of Xpert on stools using the 0.6-g and swab samples was 44.4% (95% confidence interval [CI], 13.7 to 78.8%) for both methods, with a specificity of >99%. The combined sensitivities of two stool tests versus the first respiratory Xpert were 70.0% (95% CI, 34.8 to 93.3) and 50.0% (95% CI, 18.7 to 81.3) for the 0.6-g and swab sample, respectively. Retesting stool specimens with nondeterminate Xpert results improved nondeterminate rates from 9.3% to 3.9% and from 8.6% to 4.3% for 0.6-g and swab samples, respectively. Overall, stool Xpert detected 14/94 (14.9%) children who initiated antituberculosis treatment, while respiratory specimens detected 23/94 (24.5%). This stool processing method is well suited for settings with low capacity for respiratory specimen collection. However, the overall sensitivity to detect confirmed and clinical TB was lower than that of respiratory specimens. More sensitive rapid molecular assays are needed to improve the utility of stools for the diagnosis of intrathoracic TB in children from resource-limited settings.
机译:儿童结核病(TB)的微生物学诊断具有挑战性,因为它依赖于受过训练的医护人员收集相对侵入性的标本,这在许多情况下是不可行的。使用分子方法可从儿童粪便中检测到结核分枝杆菌,但处理粪便标本需要大量资源。摘要儿童结核病的微生物学诊断具有挑战性,因为它依赖于训练有素的医护人员收集相对侵入性的标本,在许多情况下这是不可行的。使用分子方法可从儿童粪便中检测到结核分枝杆菌,但处理粪便标本需要大量资源。我们使用两种不同的粪便质量:0.6 g和拭子样品,评估了用于Xpert MTB / RIF分析(Xpert)的粪便样本的新颖,简单,无离心处理方法。从南非的两个地方招募了280名怀疑患有胸腔内结核的儿童(中位年龄为15.5个月; 35 [12.5%] HIV感染)。与对呼吸道样本进行单次Xpert测试相比,两种方法使用0.6-g和拭子样本对粪便进行Xpert的灵敏度均为44.4%(95%置信区间[CI]为13.7至78.8%),特异性> 99%。对于0.6克和拭子样品,两次粪便测试与第一次呼吸Xpert的综合敏感性分别为70.0%(95%CI,34.8至93.3)和50.0%(95%CI,18.7至81.3)。用不确定的Xpert重新测试粪便样品后,对于0.6克和拭子样品,不确定性的比率分别从9.3%提高到3.9%和从8.6%提高到4.3%。总体而言,粪便Xpert检测出发起抗结核治疗的儿童为14/94(14.9%),而呼吸道标本检测为23/94(24.5%)。这种粪便处理方法非常适合用于呼吸道标本采集能力较低的环境。但是,检测确诊和临床结核病的总体敏感性低于呼吸道标本。需要更灵敏的快速分子检测来提高粪便在资源有限的儿童中诊断胸腔内结核的效用。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号